Joe Derrigo vertritt etablierte und aufstrebende Unternehmen in allen Phasen ihres Geschäftslebenszyklus. Er ist Partner in den Bereichen Transaktionen und Risikokapital sowie Gesundheitswesen und Biowissenschaften, innovative Technologien und Cannabis, wo er interdisziplinäre Teams bei der Verhandlung komplexer Fusionen und Übernahmen, Risikokapitalfinanzierungen, Joint Ventures und Handelsgeschäften leitet.

In the emerging company space, Joe represents venture capital and other strategic investors placing growth capital and counsels operating companies on formation, governance, capital raising, and commercial matters. His emerging company clients have described him as a “de-facto member of the c-suite” on account of his practical, business-focused approach to negotiating critical commercial agreements, joint ventures, and other arrangements key to ongoing operations. His dual experience representing emerging companies and investors promotes a 360-degree approach to complex venture financing and governance issues.

Joe also has a dynamic mergers and acquisitions and commercial counseling practice, representing operating companies and financial and strategic buyers and sellers across a wide range of industries. In health care and life sciences, he advises on mergers and acquisitions, controlling and non-controlling investments, technology-intensive joint ventures, royalty financings, and other transactions underpinning product discovery and development. His life sciences clients include emerging companies, academic medical institutions, hospital systems, serial investors and prominent pharmaceutical companies. In the cannabis industry, he negotiates mergers and acquisitions, complex joint ventures, and debt and equity financing transactions for clients ranging from prominent multistate operators to individual license holders. Joe’s client base otherwise spans the software, consumer goods, finance, media, sports and entertainment, manufacturing, and government contracting industries, among others.